Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry

被引:2
|
作者
Czeti, Agnes [1 ]
Szaloki, Gabor [1 ]
Varga, Gergely [2 ]
Szita, Virag Reka [2 ]
Komlosi, Zsolt Istvan [3 ]
Takacs, Ferenc [1 ]
Mark, Agnes [1 ]
Timar, Botond [1 ]
Matolcsy, Andras [1 ]
Barna, Gabor [1 ]
机构
[1] Semmelweis Univ, Fac Med, Dept Pathol & Expt Canc Res 1, Ulloi Ut 26, Budapest, Hungary
[2] Semmelweis Univ, Dept Internal Med & Haematol, Fac Med, Budapest, Hungary
[3] Semmelweis Univ, Fac Med, Dept Genet Cell & Immunobiol, Budapest, Hungary
关键词
CLIMP-63; flow cytometry; immunophenotyping; intracellular labeling; plasma cell myeloma; VS38c; MINIMAL RESIDUAL DISEASE; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODY; EXPRESSION; MEMBRANES; PERMEABILIZATION; RESISTANCE; BLOOD; CD38;
D O I
10.1002/cyto.a.24488
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Plasma cell myeloma (multiple myeloma [MM]) is a malignant neoplasm originating from the plasma cells. Besides other methods, flow cytometric analysis of the patient's bone marrow aspirate has an important role in the diagnosis and also in the response assessment. Since the cell surface markers, used for identifying abnormal plasma cells, are expressed diversely and the treatment can also alter the phenotype of the plasma cells, there is an increasing demand for new plasma cell markers. VS38c is a monoclonal antibody that recognizes the CLIMP-63 protein in the membrane of the endoplasmic reticulum. CLIMP-63 is known to be expressed at high levels in normal and pathologic plasma cells in the bone marrow, thus VS38c antibody can be used to identify them. Although VS38c staining of plasma cells is reported to be constant and strong even in myeloma, we were wondering whether sample preparation can affect the staining. We have investigated the effect of different permeabilization agents and washing of the cells on the quality of the VS38c staining and found that in many cases the staining is inadequate to identify the plasma cells. We measured the VS38c staining of the bone marrow aspirates of 196 MM patients and observed that almost all cases showed bright staining with VS38c. However, permeabilization with mild detergent resulted in the appearance of a significant VS38c(dim) subpopulation, which showed increased sensitivity to mechanical stress (centrifugation). Our results indicate that VS38c(dim) MM cells can appear due to the improper permeabilization of the endoplasmic reticulum and this finding raises the possibility of the existence of a plasma cell subpopulation with different membrane properties. The significance of this population is unclear yet, but these cells can be easily missed with VS38c staining and can be lost due to centrifugation-induced lysis during sample preparation.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [1] The immunophenotypic stability of plasma cell myeloma by flow cytometry
    Spears, M. D.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (05) : 483 - 491
  • [2] VS38c shows lack of specificity as a marker of plasma cells
    Thomas, G
    Kay, EW
    Nyhan, B
    Leader, MB
    APPLIED IMMUNOHISTOCHEMISTRY, 1997, 5 (03): : 185 - 188
  • [3] VS38 as a promising CD38 substitute antibody for flow cytometric detection of plasma cells in the daratumumab era
    Mizuta, Shumpei
    Kawata, Takahito
    Kawabata, Hiroshi
    Yamane, Noriko
    Mononobe, Saya
    Komai, Takao
    Koba, Yusuke
    Ukyo, Naoya
    Tamekane, Akira
    Watanabe, Mitsumasa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (03) : 322 - 330
  • [4] Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study
    Zheng, Wenli
    Liu, Dingshen
    Fan, Xiangshan
    Powers, Linda
    Goswami, Maitrayee
    Hu, Ying
    Lin, Pei
    Medeiros, L. Jeffrey
    Wang, Sa A.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84B (04) : 222 - 228
  • [5] Flow cytometric aberrancies in plasma cell myeloma and MGUS - correlation with laboratory parameters
    Gupta, Sarika
    Karandikar, Nitin J.
    Ginader, Timothy
    Bellizzi, Andrew M.
    Holman, Carol J.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2018, 94 (03) : 500 - 508
  • [6] Utility of Flow Cytometry and Fluorescence In Situ Hybridization in Follow-up Monitoring of Plasma Cell Myeloma
    Chopra, Saurav
    Dunham, Timothy
    Syrbu, Sergei, I
    Karandikar, Nitin J.
    Darbro, Benjamin W.
    Holman, Carol J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (02) : 198 - 204
  • [7] Detection of myeloma cells in the peripheral blood by flow cytometry
    Witzig, TE
    Kimlinger, TK
    Ahmann, GJ
    Katzmann, JA
    Greipp, PR
    CYTOMETRY, 1996, 26 (02): : 113 - 120
  • [8] AN APPROACH FOR PLASMA CELL MYELOMA DIAGNOSIS BY TWO-COLOR FLOW CYTOMETRY BASED ON KAPPA/LAMBDA RATIOS OF CD38-GATED PLASMA CELLS
    Nakayama, S.
    Yokote, T.
    Hirata, Y.
    Iwaki, K.
    Akioka, T.
    Miyoshi, T.
    Takayama, A.
    Nishiwaki, U.
    Masuda, Y.
    Ikemoto, T.
    Tanaka, H.
    Nishimura, Y.
    Tsuji, M.
    Hanafusa, T.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2013, 26 (02) : 479 - 483
  • [9] An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138+ cells
    Nakayama, Shoko
    Yokote, Taiji
    Hirata, Yuji
    Iwaki, Kazuki
    Akioka, Toshikazu
    Miyoshi, Takuji
    Takayama, Ayami
    Nishiwaki, Uta
    Masuda, Yuki
    Ikemoto, Toshiyuki
    Tanaka, Hidema
    Nishimura, Yasuichiro
    Tsuji, Motomu
    Hanafusa, Toshiaki
    DIAGNOSTIC PATHOLOGY, 2012, 7
  • [10] Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma
    Bae, Mi Hyun
    Park, Chan-Jeoung
    Kim, Bo Hyun
    Cho, Young-Uk
    Jang, Seongsoo
    Lee, Dong-Hyun
    Seo, Eul-Ju
    Yoon, Dok Hyun
    Lee, Jung-Hee
    Suh, Cheolwon
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2018, 94 (03) : 493 - 499